iShares SLI UCITS ETF (DE) is a equity ETF from iShares tracking the SLI index through physical replication. Domiciled in Germany and launched in 2001, the fund manages about 575 M € and charges a TER of 0.51% — 51 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
iShares SLI UCITS ETF (DE) competes with 1 other products on the same index (SLI): it ranks 1st by fund size and 2nd by ongoing cost, with a TER of 0.51% against a group median of 0.39%. It has been listed since 2001, 25 years of track record.
On a €10,000 investment the TER costs 51 € a year. The cheapest of the group is Xtrackers SLI UCITS ETF 1D EUR at 0.26%, or 26 € on the same amount: a difference of 25 € every year, roughly 250 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 61.0% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Germany, which determines the tax treatment of income received by the fund and the supervisory authority.
| UBS Group AG | 9.1% |
| Nestle S.A. | 8.9% |
| Novartis AG | 8.8% |
| Roche Holding AG | 8.7% |
| ABB Ltd | 4.6% |
| Compagnie Financière Richemont SA | 4.6% |
| Zurich Insurance Group AG | 4.5% |
| Holcim AG | 4.0% |
| Swiss Re AG | 3.9% |
| Lonza Group AG | 3.9% |
| XETRA | EXI1 | EUR |
| Francoforte | EXI1 | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.